Quick Takeaways
- ACORN BIOVENTURES, L.P. filed SCHEDULE 13G/A for Athira Pharma, Inc. Common Stock, $0.0001 Par Value (ATHA).
- Disclosed ownership: 6.2%.
- Date of event: 06 Jan 2026.
ACORN BIOVENTURES, L.P. - 06 Jan 2026 SCHEDULE 13G/A Report for Athira Pharma, Inc. Common Stock, $0.0001 Par Value (ATHA)
- Filing Manager
- ACORN BIOVENTURES, L.P.
- Reporting Manager
- Anders Hove
- Symbol
- ATHA
- Shares outstanding
- 9,614,000 shares
- Disclosed Ownership
- 596,068 shares
- Ownership
- 6.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 08 Jan 2026, 17:29:25 UTC
- Date of event
- 06 Jan 2026
- Previous filing
- 23 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ACORN BIOVENTURES, L.P. disclosed 6.2% ownership in Athira Pharma, Inc. Common Stock, $0.0001 Par Value (ATHA) on 06 Jan 2026."
What Changed
- Previous schedule filing date: 23 Dec 2025.
- Current filing was accepted on 08 Jan 2026, 17:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ACORN BIOVENTURES, L.P. | 2.6% | 250,348 | 0 | 250,348 | Anders Hove | Manager of General Partner | |
| ACORN CAPITAL ADVISORS GP, LLC | 2.6% | 250,348 | 0 | 250,348 | Anders Hove | Manager | |
| ACORN BIOVENTURES 2, L.P. | 3.6% | 345,720 | 0 | 345,720 | Anders Hove | Manager of General Partner | |
| Acorn Capital Advisors GP 2, LLC | 3.6% | 345,720 | 0 | 345,720 | Anders Hove | Manager | |
| Anders Hove | 6.2% | 596,068 | 0 | 596,068 | Anders Hove | Individually |